Literature DB >> 30860105

Primary angiitis of the central nervous system: Clinical profiles and outcomes of 45 patients.

Soumya Sundaram1, Deepak Menon1, Pooja Khatri2, Sapna Erat Sreedharan1, E R Jayadevan3, Prabhakaran Sarma4, Christian Pagnoux5, P N Sylaja1.   

Abstract

OBJECTIVE: To describe the clinical profile, treatment response and predictors of outcome in patients with primary angiitis of the central nervous system (PACNS) from a single tertiary care center.
METHODOLOGY: Retrospective analysis of consecutive patients diagnosed with PACNS from January 2000 to December 2015. Outcome was defined as poor when the 6-month modified Rankin scale (mRS) was ≥3.
RESULTS: The median age of the 45 patients included in this study was 36 (range 19-70) years at disease onset and 31 (68.9%) were males. The initial presentation was ischemic stroke in 15 (33.3%), hemorrhagic stroke in 4 (8.9%), headache in 11 (24.4%), seizures in 8 (17.8%) and cognitive dysfunction in 5 (11.1%) patients. Diagnosis was confirmed by a four vessel cerebral digital subtraction angiogram (DSA), biopsy and by both biopsy and DSA in 26 (57.8%), 15 (33.3%) and 4 (8.9%) patients, respectively. All patients received glucocorticoids and 14 patients received in addition either cyclophosphamide or azathioprine as their first treatment. The median duration of follow-up was 33.1 (0.7-356) months. A poor 6-month outcome was observed in 12 (26.7%) patients. Relapse occurred in 25 (55.6%) patients and 7 (15.6%) died. Predictors of a poor outcome consisted of cognitive dysfunction at diagnosis (80% vs 20%; P = 0.014) and NIHSS ≥5 (62.5% vs 37.5%; P <.0005). None of the patients with a normal EEG had a poor outcome (P = 0.046). Predictors of relapse were a higher NIHSS at admission (P =.032) and a normal DSA (P = 0.002).
CONCLUSION: In this cohort, severe deficits and cognitive symptoms at onset and an abnormal EEG were associated with a poor 6-month outcome.

Entities:  

Keywords:  Brain biopsy; CNS vasculitis; PACNS; cognitive dysfunction; outcome; primary angiitis of central nervous system; relapse; stroke

Mesh:

Substances:

Year:  2019        PMID: 30860105     DOI: 10.4103/0028-3886.253578

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  4 in total

1.  High-Resolution Vessel Wall Imaging in Primary Angiitis of Central Nervous System.

Authors:  Soumya Sundaram; P Naveen Kumar; Dev Prakash Sharma; Chandrasekharan Kesavadas; Sapna Erat Sreedharan; B Arun Prasad; P N Sylaja
Journal:  Ann Indian Acad Neurol       Date:  2021-05-21       Impact factor: 1.383

Review 2.  Central and Peripheral Nervous System Complications of Vasculitis Syndromes From Pathology to Bedside: Part 1-Central Nervous System.

Authors:  Gelsomina Mansueto; Giuseppe Lanza; Francesco Fisicaro; Danielle Alaouieh; Emily Hong; Sara Girolami; Marco Montella; Alessandro Feola; Mario Di Napoli
Journal:  Curr Neurol Neurosci Rep       Date:  2022-02-09       Impact factor: 6.030

3.  Primary CNS vasculitis (PCNSV): a cohort study.

Authors:  Ayush Agarwal; Jyoti Sharma; M V Padma Srivastava; M C Sharma; Rohit Bhatia; Deepa Dash; Vinay Goyal; Achal K Srivastava; Manjari Tripathi; Vaishali Suri; Mamta B Singh; Sushant Agarwal; Chitra Sarkar; Leve Joseph; Manmohan Singh; Ashish Suri; Rajesh K Singh; Deepti Vibha; Awadh K Pandit; Roopa Rajan; Anu Gupta; A Elavarasi; Divya M Radhakrishnan; Animesh Das; Shailesh Gaikwad; Vivek Tandon; Ramesh Doddamani; Ashish Upadhyay; Ajay Garg; Venugopalan Y Vishnu
Journal:  Sci Rep       Date:  2022-08-05       Impact factor: 4.996

4.  The rare case of a 20-year-old male with rapidly progressive primary angiitis of the CNS with a good outcome.

Authors:  Edith Graham; Thomas Shoemaker; Dusan Stefoski; Marinos Kontzialis; Anam Naumaan; Rajeev K Garg
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-06-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.